Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mokdad, 2014, Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis, BMC Med, 12, 145, 10.1186/s12916-014-0145-y
Tapper, 2018, Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study, BMJ, 362, k2817, 10.1136/bmj.k2817
Asrani, 2013, Underestimation of liver-related mortality in the United States, Gastroenterology, 145, 375, 10.1053/j.gastro.2013.04.005
2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7
Pimpin, 2018, Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies, J Hepatol, 69, 718, 10.1016/j.jhep.2018.05.011
Byass, 2014, The global burden of liver disease: a challenge for methods and for public health, BMC Med, 12, 159, 10.1186/s12916-014-0159-5
Wong, 2019, The changing epidemiology of liver diseases in the Asia-Pacific region, Nat Rev Gastroenterol Hepatol, 16, 57, 10.1038/s41575-018-0055-0
Younossi, 2019, Non-alcoholic fatty liver disease - a global public health perspective, J Hepatol, 70, 531, 10.1016/j.jhep.2018.10.033
Liangpunsakul, 2016, Alcoholic liver disease in Asia, Europe, and North America, Gastroenterology, 150, 1786, 10.1053/j.gastro.2016.02.043
Choi, 2017, Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population, Hepatology, 66, 1454, 10.1002/hep.29321
Hadler, 2013, The impact of hepatitis B vaccine in China and in the China GAVI Project, Vaccine, 31, J66, 10.1016/j.vaccine.2013.03.043
Flemming, 2019, Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study, Lancet Gastroenterol Hepatol, 4, 217, 10.1016/S2468-1253(18)30339-X
Beste, 2015, Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013, Gastroenterology, 149, 1471, 10.1053/j.gastro.2015.07.056
Scaglione, 2015, The epidemiology of cirrhosis in the United States: a population-based study, J Clin Gastroenterol, 49, 690, 10.1097/MCG.0000000000000208
Kanwal, 2016, Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans, Clin Gastroenterol Hepatol, 14, 301, 10.1016/j.cgh.2015.08.010
Moon, 2017, Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents, Aliment Pharmacol Ther, 45, 1201, 10.1111/apt.14021
Younossi, 2019, Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, Hepatology, 69, 2672, 10.1002/hep.30251
Sayiner, 2016, Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world, Clin Liver Dis, 20, 205, 10.1016/j.cld.2015.10.001
Kanwal, 2017, Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents, Gastroenterology, 153, 996, 10.1053/j.gastro.2017.06.012
Hofmeister, 2019, Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016, Hepatology, 69, 1020, 10.1002/hep.30297
Mokdad, 2016, Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 387, 2383, 10.1016/S0140-6736(16)00648-6
Falla, 2018, Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups, BMC Infect Dis, 18, 79, 10.1186/s12879-018-2988-x
World Health Organization. Global hepatitis report 2017. 2019:2017. Available at: https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf;jsessionid=614316A7CDDB72987F9D845B0CE31136?sequence=1. Accessed March 6, 2019.
Denniston, 2014, Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010, Ann Intern Med, 160, 293, 10.7326/M13-1133
2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, Lancet Gastroenterol Hepatol, 2, 161, 10.1016/S2468-1253(16)30181-9
Centers for Disease Control and Prevention (CDC). Viral hepatitis surveillance United States, 2016. 2019:2018. Available at: https://www.cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf. Accessed March 6, 2019.
Stanaway, 2016, The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, Lancet, 388, 1081, 10.1016/S0140-6736(16)30579-7
Wong, 2018, Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment, Am J Gastroenterol, 113, 1329, 10.1038/s41395-018-0033-8
2015, Medicines use and spending shifts
Elsharkawy, 2018, Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience, J Hepatol, 68, 691, 10.1016/j.jhep.2017.11.034
Scott, 2018, Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020, J Hepatol, 68, 932, 10.1016/j.jhep.2017.12.013
Chikovani, 2019, On the way to hepatitis C elimination in the Republic of Georgia–barriers and facilitators for people who inject drugs for engaging in the treatment program: a formative qualitative study, PLoS One, 14, 10.1371/journal.pone.0216123
Jain, 2019, Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis, Hepatology, 70, 40, 10.1002/hep.30638
Cooke, 2019, Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission, Lancet Gastroenterol Hepatol, 4, 135, 10.1016/S2468-1253(18)30270-X
Yehia, 2014, The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis, PLoS One, 9, 10.1371/journal.pone.0101554
Wiessing, 2014, Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention, PLoS One, 9, 10.1371/journal.pone.0103345
Marshall, 2018, Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe, Lancet Gastroenterol Hepatol, 3, 125, 10.1016/S2468-1253(17)30284-4
National Viral Hepatitis Roundtable. Hepatitis C: the state of Medicaid access. In: Innovation CfHLaP, ed: Harvard Law School, 2017. Available at: https://hepcstage.wpengine.com/wp-content/uploads/2017/10/State-of-HepC_2017_FINAL.pdf.
Kim, 2019, Awareness of chronic viral hepatitis in the United States: an update from National Health and Nutrition Examination Survey, J Viral Hepat, 26, 596, 10.1111/jvh.13060
Kasting, 2018, Hepatitis C virus screening trends: serial cross-sectional analysis of the national health interview survey population, 2013-2015, Cancer Epidemiol Biomarkers Prev, 27, 503, 10.1158/1055-9965.EPI-17-0855
Goldberg, 2017, Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation, Gastroenterology, 152, 1090, 10.1053/j.gastro.2017.01.003
Morse, 2018, Individual state hepatitis C data supports expanding screening beyond baby boomers to all adults, Gastroenterology, 154, 1850, 10.1053/j.gastro.2018.02.035
Ott, 2017, Time trends of chronic HBV infection over prior decades - a global analysis, J Hepatol, 66, 48, 10.1016/j.jhep.2016.08.013
Le, 2020, Chronic hepatitis B prevalence among foreign-born and US-born adults in the United States, 1999-2016, Hepatology, 71, 431, 10.1002/hep.30831
Brown, 2016, Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis, Hepatology, 63, 319, 10.1002/hep.28302
Schweitzer, 2015, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013, Lancet, 386, 1546, 10.1016/S0140-6736(15)61412-X
Uribe, 2016, Rates of treatment eligibility in follow-up of patients with chronic hepatitis B (CHB) across various clinical settings who were initially ineligible at presentation, Dig Dis Sci, 61, 618, 10.1007/s10620-015-3982-4
Hutin, 2018, Access to treatment for hepatitis B virus infection - worldwide, 2016, MMWR Morb Mortal Wkly Rep, 67, 773, 10.15585/mmwr.mm6728a2
Kabbany, 2017, Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of National Health and Nutrition Examination Survey data, Am J Gastroenterol, 112, 581, 10.1038/ajg.2017.5
Allen, 2018, Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study, Hepatology, 67, 1726, 10.1002/hep.29546
Balp, 2019, The burden of nonalcoholic steatohepatitis (NASH) among patients from Europe: a real-world patient-reported outcomes study, JHEP Reports, 10.1016/j.jhepr.2019.05.009
Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease–meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431
Li, 2019, Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 4, 389, 10.1016/S2468-1253(19)30039-1
Rich, 2018, Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 16, 198, 10.1016/j.cgh.2017.09.041
Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466
Bedogni, 2007, Incidence and natural course of fatty liver in the general population: the Dionysos study, Hepatology, 46, 1387, 10.1002/hep.21827
Zhou, 2012, Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study, J Dig Dis, 13, 153
Wong, 2015, Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy, J Hepatol, 62, 182, 10.1016/j.jhep.2014.08.041
Zelber-Sagi, 2014, Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease, Liver Int, 34, e128, 10.1111/liv.12318
Chang, 2016, Metabolically healthy obesity and the development of nonalcoholic fatty liver disease, Am J Gastroenterol, 111, 1133, 10.1038/ajg.2016.178
Ogden, 2012, Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010, JAMA, 307, 483, 10.1001/jama.2012.40
Zimmermann, 2015, Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register, BMJ Open, 5, 10.1136/bmjopen-2014-006998
Hagstrom, 2016, Overweight in late adolescence predicts development of severe liver disease later in life: a 39years follow-up study, J Hepatol, 65, 363, 10.1016/j.jhep.2016.03.019
Anderson, 2015, The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis, PLoS One, 10, 10.1371/journal.pone.0140908
Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466
Rehm, 2013, Global burden of alcoholic liver diseases, J Hepatol, 59, 160, 10.1016/j.jhep.2013.03.007
Sheron, 2016, Alcohol and liver disease in Europe–simple measures have the potential to prevent tens of thousands of premature deaths, J Hepatol, 64, 957, 10.1016/j.jhep.2015.11.006
2017, Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1151, 10.1016/S0140-6736(17)32152-9
Mellinger, 2018, The high burden of alcoholic cirrhosis in privately insured persons in the United States, Hepatology, 68, 872, 10.1002/hep.29887
World Health Organization. Global status report on alcohol and health, 2018. Available at https://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1. Accessed March 6, 2019.
Wong, 2019, Prevalence of alcoholic fatty liver disease among adults in the United States, 2001-2016, JAMA, 321, 1723, 10.1001/jama.2019.2276
Yang, 2008, Epidemiology of alcohol-related liver and pancreatic disease in the United States, Arch Intern Med, 168, 649, 10.1001/archinte.168.6.649
Gao, 2011, Alcoholic liver disease: pathogenesis and new therapeutic targets, Gastroenterology, 141, 1572, 10.1053/j.gastro.2011.09.002
Simpson, 2019, Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study, Lancet Public Health, 4, e41, 10.1016/S2468-2667(18)30230-5
Huang, 2017, Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: a large tertiary referral hospital experience from 7422 patients, Medicine (Baltimore), 96
Damgaard Sandahl, 2014, Alcoholic hepatitis, Dan Med J, 61, B4755
Shah, 2019, Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide, Clin Gastroenterol Hepatol, 17, 2320, 10.1016/j.cgh.2019.01.026
2018, Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 392, 1015, 10.1016/S0140-6736(18)31310-2
Mehta, 2019, No safe level of alcohol consumption - implications for global health, J Hepatol, 70, 587, 10.1016/j.jhep.2018.12.021
Kim, 2000, Epidemiology and natural history of primary biliary cirrhosis in a US community, Gastroenterology, 119, 1631, 10.1053/gast.2000.20197
Hurlburt, 2002, Prevalence of autoimmune liver disease in Alaska natives, Am J Gastroenterol, 97, 2402, 10.1111/j.1572-0241.2002.06019.x
Boonstra, 2012, Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review, J Hepatol, 56, 1181, 10.1016/j.jhep.2011.10.025
Lu, 2018, Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment, Clin Gastroenterol Hepatol, 16, 1342, 10.1016/j.cgh.2017.12.033
Murillo Perez, 2018, Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history, Hepatology, 67, 1920, 10.1002/hep.29717
Kingham, 2004, Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom, Gastroenterology, 126, 1929, 10.1053/j.gastro.2004.04.052
Lindkvist, 2010, Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden, Hepatology, 52, 571, 10.1002/hep.23678
Bambha, 2003, Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community, Gastroenterology, 125, 1364, 10.1016/j.gastro.2003.07.011
Gronbaek, 2014, Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study, J Hepatol, 60, 612, 10.1016/j.jhep.2013.10.020
Feld, 2003, Epidemiology of autoimmune liver disease, J Gastroenterol Hepatol, 18, 1118, 10.1046/j.1440-1746.2003.03165.x
Werner, 2008, Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study, Scand J Gastroenterol, 43, 1232, 10.1080/00365520802130183
Ngu, 2010, Population-based epidemiology study of autoimmune hepatitis: a disease of older women?, J Gastroenterol Hepatol, 25, 1681, 10.1111/j.1440-1746.2010.06384.x
Delgado, 2013, Autoimmune hepatitis in southern Israel: a 15-year multicenter study, J Dig Dis, 14, 611
Adams, 2005, Hemochromatosis and iron-overload screening in a racially diverse population, N Engl J Med, 352, 1769, 10.1056/NEJMoa041534
Beutler, 2002, Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0
Adams, 2006, Liver diseases in the hemochromatosis and iron overload screening study, Clin Gastroenterol Hepatol, 4, 918, 10.1016/j.cgh.2006.04.013
McCune, 2002, Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload, Hum Genet, 111, 538, 10.1007/s00439-002-0824-1
Coffey, 2013, A genetic study of Wilson's disease in the United Kingdom, Brain, 136, 1476, 10.1093/brain/awt035
Tapper, 2013, The overuse of serum ceruloplasmin measurement, Am J Med, 126, 926, 10.1016/j.amjmed.2013.01.039
El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001
Tansel, 2017, Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: A systematic review and meta-analysis, Clin Gastroenterol Hepatol, 15, 1207, 10.1016/j.cgh.2017.02.006
Mittal, 2018, Role of age and race in the risk of hepatocellular carcinoma in veterans with hepatitis B virus infection, Clin Gastroenterol Hepatol, 16, 252, 10.1016/j.cgh.2017.08.042
Akinyemiju, 2017, The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015, JAMA Oncol, 3, 1683, 10.1001/jamaoncol.2017.3055
Sun, 2013, Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China, Carcinogenesis, 34, 1800, 10.1093/carcin/bgt007
Altekruse, 2014, Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States, Am J Gastroenterol, 109, 542, 10.1038/ajg.2014.11
Nasir, 2017, Markedly increased rate of primary liver malignancies at autopsy in male US veterans, Clin Gastroenterol Hepatol, 15, 316, 10.1016/j.cgh.2016.08.025
White, 2017, Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012, Gastroenterology, 152, 812, 10.1053/j.gastro.2016.11.020
Rich, 2020, Hepatocellular carcinoma incidence is decreasing among younger adults in the United States, Clin Gastroenterol Hepatol, 18, 242, 10.1016/j.cgh.2019.04.043
Ioannou, 2018, Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C, J Hepatol, 69, 1088, 10.1016/j.jhep.2018.07.024
El-Serag, 2007, Epidemiology of hepatocellular carcinoma in Hispanics in the United States, Arch Intern Med, 167, 1983, 10.1001/archinte.167.18.1983
El-Serag, 2012, Epidemiology of viral hepatitis and hepatocellular carcinoma, Gastroenterology, 142, 1264, 10.1053/j.gastro.2011.12.061
Rich, 2019, Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma, Clin Gastroenterol Hepatol, 17, 551, 10.1016/j.cgh.2018.05.039
D'Amico, 2006, Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol, 44, 217, 10.1016/j.jhep.2005.10.013
D'Amico, 2018, Clinical states of cirrhosis and competing risks, J Hepatol, 68, 563, 10.1016/j.jhep.2017.10.020
D'Amico, 2014, Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients, Aliment Pharmacol Ther, 39, 1180, 10.1111/apt.12721
Ratib, 2015, Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study, Am J Gastroenterol, 110, 1149, 10.1038/ajg.2015.191
Fleming, 2010, The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study, Aliment Pharmacol Ther, 32, 1343, 10.1111/j.1365-2036.2010.04473.x
Tapper EB, Parikh ND, Sengupta N, et al. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. 2018;68:1498–1507.
Fleming, 2012, All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study, Liver Int, 32, 79, 10.1111/j.1478-3231.2011.02517.x
Bajaj, 2017, Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures, Clin Gastroenterol Hepatol, 15, 565, 10.1016/j.cgh.2016.09.157
Peery, 2019, Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018, Gastroenterology, 156, 254, 10.1053/j.gastro.2018.08.063
Piano, 2019, Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide, Gastroenterology, 156, 1368, 10.1053/j.gastro.2018.12.005
Angeli, 2015, Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites, J Hepatol, 62, 968, 10.1016/j.jhep.2014.12.029
Mindikoglu, 2018, New developments in hepatorenal syndrome, Clin Gastroenterol Hepatol, 16, 162, 10.1016/j.cgh.2017.05.041
Montoliu, 2010, Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites, Clin Gastroenterol Hepatol, 8, 616, 10.1016/j.cgh.2010.03.029
Piano, 2013, Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites, J Hepatol, 59, 482, 10.1016/j.jhep.2013.03.039
Gines, 1993, Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites, Gastroenterology, 105, 229, 10.1016/0016-5085(93)90031-7
Martin-Llahi, 2011, Prognostic importance of the cause of renal failure in patients with cirrhosis, Gastroenterology, 140, 488, 10.1053/j.gastro.2010.07.043
Lai, 2014, Frailty predicts waitlist mortality in liver transplant candidates, Am J Transplant, 14, 1870, 10.1111/ajt.12762
Lai, 2017, Development of a novel frailty index to predict mortality in patients with end-stage liver disease, Hepatology, 66, 564, 10.1002/hep.29219
Tapper, 2015, Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosis, Clin Gastroenterol Hepatol, 13, 1670, 10.1016/j.cgh.2015.03.019
Tapper, 2019, Frailty, psychoactive medications, and cognitive dysfunction are associated with poor patient-reported outcomes in cirrhosis, Hepatology, 69, 1676, 10.1002/hep.30336
Rakoski, 2012, Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study, Hepatology, 55, 184, 10.1002/hep.24616
Lai, 2016, Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study, Hepatology, 63, 574, 10.1002/hep.28316
Lai, 2016, Performance-based measures associate with frailty in patients with end-stage liver disease, Transplantation, 100, 2656, 10.1097/TP.0000000000001433
Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042
Arroyo, 2015, Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis, J Hepatol, 62, S131, 10.1016/j.jhep.2014.11.045
Bajaj, 2014, Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures, Hepatology, 60, 250, 10.1002/hep.27077
Hernaez, 2019, Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure, J Hepatol, 71, 638, 10.1016/j.jhep.2019.06.004
Gustot, 2015, Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, 62, 243, 10.1002/hep.27849
Allen, 2016, Time trends in the health care burden and mortality of acute on chronic liver failure in the United States, Hepatology, 64, 2165, 10.1002/hep.28812
Asrani, 2019, Trends in chronic liver disease-related hospitalizations: a population-based study, Am J Gastroenterol, 114, 98, 10.1038/s41395-018-0365-4
Stepanova, 2017, Direct and indirect economic burden of chronic liver disease in the United States, Clin Gastroenterol Hepatol, 15, 759, 10.1016/j.cgh.2016.07.020
Tapper, 2016, Preventing and treating acute kidney injury among hospitalized patients with cirrhosis and ascites: a narrative review, Am J Med, 129, 461, 10.1016/j.amjmed.2015.12.006
Tapper, 2016, Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study, Clin Gastroenterol Hepatol, 14, 1181, 10.1016/j.cgh.2016.04.009
Tapper, 2017, Strategies to reduce 30-day readmissions in patients with cirrhosis, Curr Gastroenterol Rep, 19, 1, 10.1007/s11894-017-0543-3
Tapper, 2017, Suboptimal implementation of evidence-based therapy for acute variceal hemorrhage: A systematic review of observational studies, Clin Gastroenterol Hepatol, 15, 1373, 10.1016/j.cgh.2017.02.018
Bajaj, 2011, The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers, Am J Gastroenterol, 106, 1646, 10.1038/ajg.2011.157
Ghabril, 2017, Most individuals with advanced cirrhosis have sleep disturbances, which are associated with poor quality of life, Clin Gastroenterol Hepatol, 15, 1271, 10.1016/j.cgh.2017.01.027
Tapper, 2018, Patient reported outcomes in cirrhosis: a scoping review of the literature, Hepatology, 67, 2375, 10.1002/hep.29756
Mapakshi, 2018, Positive predictive value of international classification of diseases, 10th revision, codes for cirrhosis and its related complications, Clin Gastroenterol Hepatol, 16, 1677, 10.1016/j.cgh.2018.01.042
Boscarino, 2015, Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS), Hepatology, 61, 802, 10.1002/hep.27422
Jepsen, 2010, Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study, Hepatology, 51, 1675, 10.1002/hep.23500
Deleuran, 2016, Decreasing mortality among Danish alcoholic cirrhosis patients: a nationwide cohort study, Am J Gastroenterol, 111, 817, 10.1038/ajg.2016.107
Kanwal, 2014, Improving quality of health care for patients with cirrhosis, Gastroenterology, 147, 1204, 10.1053/j.gastro.2014.10.029
World Health Organization. WHO calls for better monitoring of viral hepatitis and liver cancer. 2019:2018. Available at: https://www.who.int/hepatitis/news-events/hepatitis-surveillance-protocol-story/en/. Accessed March 14, 2019.
Parkin, 2006, The evolution of the population-based cancer registry, Nat Rev Cancer, 6, 603, 10.1038/nrc1948
Ratib, 2017, Liver cirrhosis in England-an observational study: are we measuring its burden occurrence correctly?, BMJ Open, 7, 10.1136/bmjopen-2016-013752
Younossi, 2016, The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe, Hepatology, 64, 1577, 10.1002/hep.28785
Kanerva, 2014, Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults, Am J Clin Nutr, 100, 1133, 10.3945/ajcn.114.086074
Riquelme, 2009, Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics, Liver Int, 29, 82, 10.1111/j.1478-3231.2008.01823.x